Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2)

NCT05918211 is registered in ClinicalTrials.gov with Mezzion Pharma Co. Ltd as lead sponsor.

NCT NCT05918211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05918211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL-2)
Lead sponsor
Mezzion Pharma Co. Ltd
Phase
Phase 3
Overall status
Recruiting
Start date
October 30, 2023
Completion date
October 28, 2025
Enrollment
436 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

single ventricle heart disease